Please login to the form below

Not currently logged in

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

Dovato approval key for Glaxo in HIV treatment

Dovato approval key for Glaxo in HIV treatment

Christopher Pace, senior director of Infectious Diseases and Respiratory at data and analytics company GlobalData, predicts the new entrant will be a blockbuster.

Latest news

More from news
Approximately 3 fully matching, plus 169 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and

  • Searching for health Searching for health

    year. The pharma work is organised into therapeutic areas covering cancers, infectious diseases, immunology, cardiovascular and metabolism diseases with each having dedicated research teams managing all aspects - from finding new compounds

  • The world is our laboratory The world is our laboratory

    Our goal is to improve patient outcomes in the most serious unmet medical needs of our time, including neglected diseases. ... Focused specialties. At Janssen, we have focused our research into five important therapeutic areas: Cardiovascular &Metabolic

  • Deal Watch October 2015 Deal Watch October 2015

    The other ventures are: Onkaido to develop mRNA drugs in oncology; Valera to develop vaccines and therapeutics for the prevention and treatment of viral and bacterial infectious diseases; and Elpidera focused ... 1, 000 ‡. Adheron Therapeutics/ Roche.

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest from PMHub

  • emotive adds to medical team with new Scientific Lead and Associate Medical Writer

    Following a busy year and with a number of new Global and EMEA account wins including two pre-launch products for rare diseases, emotive has strengthened the medical team with the ... in rare diseases such as Gaucher disease and Cushing’s disease

  • PRMA Consulting Ltd

    Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,

  • Australian Flu and the dilemma of naming diseases

    In recent times, the potentially damaging consequences of ‘naming’ infectious diseases have been identified, and in 2015 the World Health Organisation (WHO) introduced its ‘Best Practices for the Naming of New ... Human Infectious Diseases’,


    cardiovascular disease . diabetes. women’s health . nutrition . allergy . infectious diseases . wound care .

  • New insights into making behavioural change work

    The focus of pharmacological interventions has experienced a shift over recent years, with a greater emphasis placed on addressing lifestyle conditions than on fighting infectious diseases. ... Lifestyle conditions, or noncommunicable diseases (NCDs),

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...